PET/CT Scans to Evaluate Thyroid and Parathyroid Conditions
Studies whether PET/CT scan results help tell apart thyroid and parathyroid conditions in adults.
Key facts
- Who runs it
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Where
- Bologna, ItalySee the site
- Trial code
- Registry title
- PET-TC in Thyroid Evaluation
- Status
- Enrolling by invitation
- People taking part
- 418 people, planned
- Started
- 14 Oct 2024
- Expected to end
- 30 Apr 2029
- Type of study
- Observational
- Treatments tested
- clinical practice drug treatment
- Record updated
- 28 February 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who had a PET/CT scan because of a finding in the thyroid or parathyroid, or who have a known thyroid or parathyroid disease.
- Age
- Over 18 years
- Sex
- All sexes
- Disease stage
- Thyroid or parathyroid finding on PET/CT, or a known thyroid or parathyroid disease.
- Biomarker or test result
- In the retrospective part, a cytology result from needle aspiration done no more than 12 months from the PET/CT.
Main reasons for not taking part
- Not giving informed consent
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- For the retrospective part:
- Patients aged >18 years,
- Findings of hypercaptant of thyroid/parathyroid relevance to PET/CT or known thyroid or parathyroid pathology and subsequent execution of PET/CT according to normal clinical practice,
- Patients with cytological examination derived from needle aspiration performed no more than 12 months time apart from PET/CT
- Obtaining informed consent; For the prospective part:
- Patients aged >18 years,
- Finding hypercaptant findings of thyroid/parathyroid relevance to PET/CT or known thyroid or parathyroid pathology and subsequent execution of PET/CT according to normal clinical practice
- Patients scheduled for agesult to be no more than 12 months
- Obtaining informed consent
Who cannot take part
- Nothing
Where in Italy
- Nuclear medicine, IRCCS, Azienda Ospedalierio-Universitaria di BolognaBologna, ItalyNo longer taking part
About the trial
What the trial wants to find out
The thyroid gland may have a diffuse or focal uptake of numerous PET/CT radiopharmaceuticals and this may be correlated with underlying benign and malignant thyroid/parathyroid pathologies.
Read full original descriptionShow less
It is not clear at present if the uptake of the radiopharmaceutical alone is associated with a potential malignancy of the disease.
The aim of the study is to collect evidence and consolidate the diagnostic power of PET/CT, to identify any predictive parameters that can determine whether PET positivity/negativity can in the future avoid unnecessary tests such as needle aspiration.
The group in the trial
- pepati group
Patients belonging to the U.O. of Nuclear Medicine IRCCS - University Hospital of Bologna - Polyclinic S. Orsola, who have performed or are to perform PET/CT for thyroid/parathyroid disease or other clinical indication with incidental detection of thyroid/parathyroid disease or patients undergoing PET/CT with known thyroid/parathyroid disease (for example, patients with thyroid nodules already subjected to needle aspiration) as part of the normal care path for a period of 5 years and 6 months.
Treatment: clinical practice drug treatment
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Ruolo Della PET/TC Nella Valutazione di Patologia Tiroidea in un Centro di Medicina Nucleare ad Alto Volume Diagnostico
- Plain-language title
- PET/CT Scans to Evaluate Thyroid and Parathyroid ConditionsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 28 February 2025